Success Metrics

Clinical Success Rate
95.2%

Based on 60 completed trials

Completion Rate
95%(60/63)
Active Trials
10(11%)
Results Posted
18%(11 trials)
Terminated
3(3%)

Phase Distribution

Ph early_phase_1
3
3%
Ph phase_2
15
16%
Ph phase_1
5
5%
Ph not_applicable
48
51%
Ph phase_4
16
17%
Ph phase_3
7
7%

Phase Distribution

8

Early Stage

15

Mid Stage

23

Late Stage

Phase Distribution94 total trials
Early Phase 1First-in-human
3(3.2%)
Phase 1Safety & dosage
5(5.3%)
Phase 2Efficacy & side effects
15(16.0%)
Phase 3Large-scale testing
7(7.4%)
Phase 4Post-market surveillance
16(17.0%)
N/ANon-phased studies
48(51.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.2%

60 of 63 finished

Non-Completion Rate

4.8%

3 ended early

Currently Active

10

trials recruiting

Total Trials

94

all time

Status Distribution
Active(12)
Completed(60)
Terminated(3)
Other(19)

Detailed Status

Completed60
unknown19
Recruiting5
Active, not recruiting5
Terminated3
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
94
Active
10
Success Rate
95.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (3.2%)
Phase 15 (5.3%)
Phase 215 (16.0%)
Phase 37 (7.4%)
Phase 416 (17.0%)
N/A48 (51.1%)

Trials by Status

recruiting55%
enrolling_by_invitation11%
terminated33%
active_not_recruiting55%
unknown1920%
completed6064%
not_yet_recruiting11%

Recent Activity

Clinical Trials (94)

Showing 20 of 94 trialsScroll for more
NCT06120140Phase 2

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Recruiting
NCT07058727Not Applicable

Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain

Recruiting
NCT06627270Phase 2

Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer

Recruiting
NCT02572791Phase 4

Staph Household Intervention for Eradication (SHINE)

Completed
NCT06598514Phase 4

Chlorhexidine Lavage for Recurrent Urinary Tract Infection

Active Not Recruiting
NCT06489431Phase 3

Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement

Active Not Recruiting
NCT07270952Phase 4

Protocol Efficacy of Mouthwashes in Experimental Gingivitis

Completed
NCT07197073Not Applicable

Antibacterial Effect of Ozonated Olive Oil, Propolis and Chlorhexidine Mouthwashes in Pediatric Patients

Completed
NCT04171817Phase 4

Animal-Assisted Visitation Program Chlorhexidine Trial

Completed
NCT07031388Not Applicable

Mouthwashes for Gingivitis: Comparing a Hydrogen Peroxide-Hyaluronic Acid Mix, Hyaluronic Acid, and Chlorhexidine, A Triple-Blind Clinical Trial

Active Not Recruiting
NCT07048899Phase 4

Irrisept in Emergency General Surgery Patients

Enrolling By Invitation
NCT07001527Phase 3

Dressing Impregnated With Chlorhexidine and Vancomycin for the Prophylaxis of Central Venous Catheter-related Infections - a Randomized Trial

Completed
NCT05913856Not Applicable

The Effectiveness of Oral Care With Chlorhexidine in Medical Intensive Care Unit

Completed
NCT06667089Not Applicable

Povidone-Iodine Versus Chlorhexidine in Surgical Wound Care

Completed
NCT06834711Not Applicable

Chlorhexidine Versus N-Asetil Sistein Irrigation in Mandibular Molar Teeth with Chronic Apical Periodontitis

Completed
NCT06811779Phase 1

Comparison of Effectiveness of Disinfectants

Completed
NCT05024760Early Phase 1

Antiseptic Effects on the Dental Implant Internal Surface Microbiome

Recruiting
NCT04225065Not Applicable

Chlorhexidine and/or Betadine Prep in Pediatric Arm Surgery Following Trauma

Terminated
NCT03503370Phase 2

Preventing Diabetic Foot Ulcers Through Cleaner Feet

Completed
NCT06435832Not Applicable

Evaluations of the Effects of Tranexamic Acid and Chlorhexidine Gel on Alveolar Osteitis Incidence

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
94